E Wolff

486 total citations
17 papers, 398 citations indexed

About

E Wolff is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, E Wolff has authored 17 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in E Wolff's work include Genomic variations and chromosomal abnormalities (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). E Wolff is often cited by papers focused on Genomic variations and chromosomal abnormalities (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Glycosylation and Glycoproteins Research (4 papers). E Wolff collaborates with scholars based in Germany, United States and Sweden. E Wolff's co-authors include Howard V. Raff, Thomas Liehr, E. Gebhart, Sabine Girod, Alejandro Aruffo, B. W. Greenfield, H Steininger, Kelly L. Bennett, Jutta Ries and Walter W. Shuford and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

E Wolff

17 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Wolff Germany	12	192	102	86	83	74	17	398
Takaomi Sekino Japan	11	234 1.2×	196 1.9×	42 0.5×	39 0.5×	93 1.3×	16	550
M Bowman United States	10	180 0.9×	53 0.5×	43 0.5×	58 0.7×	130 1.8×	12	350
Teruaki Oku Japan	15	215 1.1×	139 1.4×	31 0.4×	51 0.6×	80 1.1×	40	556
Gaelle Kustermans Belgium	10	185 1.0×	147 1.4×	50 0.6×	28 0.3×	66 0.9×	10	444
Takehiko Tachibana Japan	12	172 0.9×	164 1.6×	96 1.1×	47 0.6×	115 1.6×	48	401
K A Smith United States	8	188 1.0×	199 2.0×	67 0.8×	83 1.0×	153 2.1×	14	555
D. Schneider Germany	11	269 1.4×	154 1.5×	58 0.7×	33 0.4×	76 1.0×	12	443
Steffen Schiffer Germany	8	393 2.0×	150 1.5×	56 0.7×	109 1.3×	72 1.0×	8	665
Richard Priest United Kingdom	12	210 1.1×	171 1.7×	92 1.1×	24 0.3×	59 0.8×	15	507
Ken Ito United States	5	193 1.0×	388 3.8×	78 0.9×	39 0.5×	76 1.0×	8	590

Countries citing papers authored by E Wolff

Since Specialization

Citations

This map shows the geographic impact of E Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Wolff more than expected).

Fields of papers citing papers by E Wolff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Wolff. The network helps show where E Wolff may publish in the future.

Co-authorship network of co-authors of E Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of E Wolff. A scholar is included among the top collaborators of E Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Wolff. E Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Gebhart, E., Thomas Liehr, E Wolff, et al.. (2003). Loss of 9p21 is embedded in a complex but consistent pattern of genomic imbalances in oral squamous cell carcinomas. Cytogenetic and Genome Research. 101(2). 106–112. 6 indexed citations

Bayerlein, Kristina, Irmgard Verdorfer, Thomas Liehr, et al.. (2000). I-FISH control of CGH-detected gain of DNA sequence copy number in oral squamous cell carcinomas (OSCC).. PubMed. 20(1A). 427–32. 8 indexed citations

Wolff, E, B. W. Greenfield, Dennis D. Taub, et al.. (1999). Generation of Artificial Proteoglycans Containing Glycosaminoglycan-modified CD44. Journal of Biological Chemistry. 274(4). 2518–2524. 28 indexed citations

Greenfield, B. W., Wei‐Chun Wang, Hans Marquardt, et al.. (1999). Characterization of the Heparan Sulfate and Chondroitin Sulfate Assembly Sites in CD44. Journal of Biological Chemistry. 274(4). 2511–2517. 57 indexed citations

Wolff, E, Sabine Girod, Thomas Liehr, et al.. (1998). Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. Oral Oncology. 34(3). 186–190. 60 indexed citations

Girod, Sabine, Sven Koscielny, H Steininger, et al.. (1998). Gain of DNA copy number on chromosomes 3q26-qter and 5p14-pter is a frequent finding in head and neck squamous cell carcinomas.. International Journal of Molecular Medicine. 2(2). 173–179. 22 indexed citations

Gebhart, E., Thomas Liehr, E Wolff, et al.. (1998). Pattern of genomic imbalances in oral squamous cell carcinomas with and without an increased copy number of 11q13.. International Journal of Oncology. 12(5). 1151–5. 18 indexed citations

Wolff, E, et al.. (1997). Frequent gains and losses of specific chromosome segments in human ovarian carcinomas shown by comparative genomic hybridization. International Journal of Oncology. 11(1). 19–23. 16 indexed citations

Wolff, E, Ingegerd Hellström, Dana F. Chace, K E Hellström, & Clay B. Siegall. (1995). Antitumour activity of a melanoma-specific immunotoxin, ME20-LysPE40.. PubMed. 2(3). 137–45. 1 indexed citations

10.

Siegall, Clay B., E Wolff, Susan L. Gawlak, et al.. (1995). Immunotoxins as cancer chemotherapeutic agents. Drug Development Research. 34(2). 210–219. 10 indexed citations

11.

Siegall, Clay B., Dana F. Chace, Bruce Mixan, et al.. (1994). In vitro and in vivo characterization of BR96 sFv-PE40. A single-chain immunotoxin fusion protein that cures human breast carcinoma xenografts in athymic mice and rats.. The Journal of Immunology. 152(5). 2377–2384. 36 indexed citations

12.

Siegall, Clay B., Susan L. Gawlak, Dana F. Chace, et al.. (1994). Characterization of Ribosome-Inactivating Proteins Isolated from Bryonia dioica and Their Utility as Carcinoma-Reactive Immunoconjugates. Bioconjugate Chemistry. 5(5). 423–429. 20 indexed citations

13.

Wolff, E, George J. Schreiber, W L Cosand, & Howard V. Raff. (1993). Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.. PubMed. 53(11). 2560–5. 30 indexed citations

14.

Wolff, E, et al.. (1992). Human monoclonal antibody homodimers. Effect of valency on in vitro and in vivo antibacterial activity. The Journal of Immunology. 148(8). 2469–2474. 12 indexed citations

15.

Raff, Howard V., et al.. (1991). Pharmacokinetic and Pharmacodynamic Analysis of a Human Immunoglobulin M Monoclonal Antibody in Neonatal Macaca fascicularis. Pediatric Research. 29(3). 310–314. 1 indexed citations

16.

Raff, Howard V., Clare Bradley, William J. Brady, et al.. (1991). Comparison of Functional Activities between IgG1 and IgM Class-Switched Human Monoclonal Antibodies Reactive with Group B Streptococci or Escherichia coli K1. The Journal of Infectious Diseases. 163(2). 346–354. 34 indexed citations

17.

Raff, Howard V., et al.. (1988). Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes.. The Journal of Experimental Medicine. 168(3). 905–917. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact